Adam Sowalsky, Ph.D.

A Conversation with Adam Sowalsky, Ph.D.

Aug 4, 2020

Adam Sowalsky, Ph.D., is an Investigator in the Laboratory of Genitourinary Cancer Pathogenesis. He is seeking to tease apart the molecular mechanisms underlying prostate cancers that have a high likelihood of progressing and then identifying patients who might benefit from earlier therapy. He discusses what motivated him to pursue a career in cancer biology as well as what lies ahead for his research. Read more...

Joe Chinquee

Joe Chinquee volunteers with Navajo Nation during COVID-19 pandemic

Jul 15, 2020

Joe Chinquee, D.H.Sc., M.B.A., M.T. (A.S.C.P.) D.L.M., Clinical and Scientific Manager of the Laboratory of Pathology, served on the frontlines of the COVID-19 pandemic. In an effort to give back, he was deployed on a month-long mission to assist the U.S. Public Health Service at the Navajo Nation in New Mexico. Chinquee said: “At the NIH, I’ve been given so many opportunities and rewards. I will never stop giving back, but I would not be able to volunteer for these missions without the full support of my NCI leadership.” Read more...

Flossie Wong-Staal, Ph.D.

In Memoriam: Flossie Wong-Staal, Ph.D.

Jul 13, 2020

The Center for Cancer Research mourns the recent death of past colleague Flossie Wong-Staal. She was a major figure in the discovery of HIV and the first to clone the virus.  Read more...

Matthew Lindsley

Lieutenant and Research Nurse Matt Lindsley shares his experiences and public service role

Jul 8, 2020

Matthew Lindsley, MPH, MSN, RN PHNA-BC, is a Lieutenant in the United States Public Health Service. As a Research Nurse Specialist for the NCI’s Center for Cancer Research, Neuro-Oncology Branch, Matt helps patients with brain and spine tumors who come to NIH for treatment. He was recently deployed to aid in the COVID-19 response mission in Washington state for a number of weeks.  Read more...

Mary Kearney

Mary Kearney discusses coronavirus with National Geographic

Jul 8, 2020

Mary Kearney, Ph.D., Senior Scientist in the Host-Virus Interaction Branch, was recently quoted in a National Geographic article discussing how long coronavirus lasts inside the body. “Where there’s long-term persistence, there can be long-term consequences,” she says.  Read more...

Gilbert Howlett Smith, Ph.D.

In Memoriam: Gilbert Howlett Smith, Ph.D.

Jul 7, 2020

The Center for Cancer Research mourns the recent death of colleague and friend Gilbert Howlett Smith, Ph.D. He was a valued and much liked member of the NCI community since 1965. Read more...

Isaiah Fidler, D.V.M, Ph.D.

In Memoriam: Isaiah Fidler, D.V.M, Ph.D.

Jun 5, 2020

The Center for Cancer Research mourns the recent death of past colleague and friend Isaiah Fidler, D.V.M., Ph.D. He joined the National Cancer Institute in 1975 and led the metastasis program at the Frederick Cancer Research Facility. His eight years at NCI produced some of his early innovative work in unraveling the riddles of how cancer spreads. Read more...

Stephen Oroszlan

In Memoriam: Stephen Oroszlan, Ph.D.

May 15, 2020

The Center for Cancer Research mourns the recent death of past colleague and friend Stephen Oroszlan. He was an esteemed member of the NCI community from 1976-1995 and served as a Scientist Emeritus since 1995.  Read more...

Eytan Ruppin

Eytan Ruppin quoted in New York Times story on treating COVID-19

May 15, 2020

The New York Times has reported on a new paper detailing drugs with the potential to treat COVID-19 by researchers from international institutions. Eytan Ruppin, Ph.D., Chief of the Cancer Data Science Laboratory, turned the computer network his lab uses toward analyzing some of the drugs that did best in the screening to predict which are likely to succeed in actual patients and in what combinations. Read more...

Ira Pastan

Ira Pastan selected as a 2020 Sammies finalist

May 4, 2020

Ira Pastan, M.D., Co-Chief of the Laboratory of Molecular Biology, has been selected as one of 27 Samuel J. Heyman Service to America Medal (Sammies) finalists. These finalists are outstanding federal employees who serve the public good and are addressing many of our country’s greatest challenges. Dr. Pastan is nominated for discovering a new class of drugs that can successfully treat a rare form of leukemia and hold promise to be effective therapies for pancreatic and lung cancer as well as mesothelioma. Read more...

Pages